A proposal of simple calculation (ERI calculator) to predict the early response to TNF-α blockers therapy in rheumatoid arthritis

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 349-356

  Bazzichi, Laura ^a   Rossi, Paolo ^a   Giacomelli, Camillo ^a   De Feo, Francesca ^a   Bobbio Pallavicini, Francesca ^b   Rossi, Alessandra ^a   Baldini, Chiara ^a   Consensi, Arianna ^a   Doveri, Marica ^a   Bonino, Claudia ^b   Mazzantini, Maurizio ^a   Della Rossa, Alessandra ^a   Montecucco, Carlomaurizio ^b   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Mathematical model; Rheumatoid Arthritis; TNF alpha blocking agents

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; HUMAN; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, IMMUNOLOGICAL; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857048329     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1619-7     Document Type: Article

References (20)

1. K Redich G Schtt G Steiner S Hayer EF Wagner JS Smolen 2003 Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade Arthritis Rheum 48 3308 3319 10.1002/art.11358 (Pubitemid 37531897)
2. Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di Franco M (2007) Biological and clinical effects of anti-TNF-alpha treatment. Autoimmun Rev 7:35-41. (Epub 2007 Mar 26) (Pubitemid 47633389)
3. C Han J Smolen A Kavanaugh D van der Heijde J Braun R Westhovens N Zhao MU Rahman D Baker M Bala 2007 The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases Arthritis Res Ther 9 103 10.1186/ar2306 (Pubitemid 350263514)
4. K Pavelka J Gatterová D Tegzová K Jarosová J Tomasová Studýnková A Svobodník J Svihálek L Dusek J Vencovský 2007 Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment Clin Exp Rheumatol 25 540 545 17888209 1:STN:280:DC%2BD2srmvVKhtg%3D%3D (Pubitemid 47455462)
5. PA Klimiuk S Sierakowski I Domyslawska J Chwiecko 2006 Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis Clin Exp Rheumatol 24 529 533 17181921 1:STN:280: DC%2BD28jktlGgtg%3D%3D (Pubitemid 44911246)
6. G Valesini C Montecucco M Cutolo 2006 Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy Clin Exp Rheumatol 24 413 423 16956432 1:STN:280:DC%2BD28rjt1eiuw%3D%3D (Pubitemid 44363543)
7. MA Gonzalez-Gay MT Garcia-Unzueta JM De Matias C Gonzalez-Juanatey C Garcia-Porrua A Sanchez-Andrade J Martin J Llorca 2006 Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis Clin Exp Rheumatol 24 373 379 16956426 1:STN:280:DC%2BD28rjt1eisQ%3D%3D (Pubitemid 44363537)
8. Navarro-Sarabia F, Ariza-Ariza R, Hernandez-Cruz B, Villanueva I (2005) Adalimumab for treating rheumatoid arthritis. Cochrane Database Syst Rev CD005113
9. MC Genovese JM Bathon RM Fleischmann, et al. 2005 Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis J Rheumatol 32 1232 1242 15996057 1:CAS:528:DC%2BD2MXnsl2nsrY%3D (Pubitemid 40995375)
10. EW St. Clair DM van der Heijde JS Smolen, et al. 2004 Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial Arthritis Rheum 50 3432 3443 15529377 10.1002/art.20568 1:CAS:528:DC%2BD2cXhtVOqtrvJ (Pubitemid 39488667)
11. AM van Gestel MLL Prevoo MA van t' Hof, et al. 1996 The development and validation of the European League against rheumatism response criteria in rheumatoid arthritis. A comparison with the preliminary American College of Rheumatology and a the WHO/international League Against Rheumatism criteria Arthritis Rheum 39 34 40 8546736 10.1002/art.1780390105 (Pubitemid 26036375)
12. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines Guidelines for the Management of Rheumatoid (2002) Arthritis & Rheumatism 46:328-346
13. AM van Gestel CJ Haagsma PL van Riel 1998 Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis Rheum 41 1845 1850 9778226 10.1002/1529-0131(199810)41:10<1845::AID- ART17>3.0.CO;2-K (Pubitemid 28465539)
14. J Fransen MC Creemers PL Van Riel 2004 Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria Rheumatology 43 1252 1255 15238643 10.1093/rheumatology/ keh297 1:STN:280:DC%2BD2cvotVyrsw%3D%3D (Pubitemid 39359299)
15. A Roy DR Mould XF Wang L Tay R Raymond M Pfister 2007 Modeling and simulation of Abatacept exposure and interleukin-6 response in support of recommended doses for Rheumatoid Arthritis J Clin Pharmacol 47 1408 1420 17962428 10.1177/0091270007307573 1:CAS:528:DC%2BD2sXhtlGru7jM (Pubitemid 47624599)
16. González-Alvaro I, Ortiz AM, Tomero EG, Balsa A, Orte J, Laffon A, García-Vicuña R (2007) Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists. Ann Rheum Dis 66(12):1675-1678
17. F Bonino P Marcellin GKK Lau S Hadziyannis R Jin T Piratvisuth G Germanidis For the Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group, et al. 2007 Predicting response to peginterferon a-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B Gut 56 699 705 17127704 10.1136/gut.2005.089722 1:CAS:528:DC%2BD2sXlvVKlt7Y%3D (Pubitemid 46662938)
18. M Pfister NE Martin LP Haskell JS Barrett 2004 Optimizing dose selection with modeling and simulation: application to the vasopeptidase inhibitor M100240 J Clin Pharmacol 44 621 631 15145970 10.1177/0091270004265365 1:CAS:528:DC%2BD2cXltV2ltb4%3D (Pubitemid 38668025)
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324 (Pubitemid 18091653)
20. I Castrejon AM Ortiz R Garcia Vicuna, et al. 2008 Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 26 760 775